drugset / Trial / NCT00206661
Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to observe pediatric Crohn's Disease response to sargramostim in patients with or without steroid therapy at two possible dosage levels.
Timeline
- Start
- 2004-12
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sargramostim | Protein / enzyme biologic | 4 ug | — |
| Subject | sargramostim | Protein / enzyme biologic | 6 ug | — |